FDA issued a Warning Letter to Aztex Enterprises Ltd. on 10/20/2017 as a result of this inspection.
483 Aztex Enterprises Jun 2017

483 Aztex Enterprises Jun 2017

John Mistler FDA$119.00 - Available Now

FDA investigators audited the Aztex Enterprises - Burlington, Canada facility and issued inspectional observations (via FDA 483) on 13 Jun 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 13 Jun 2017
  • Location: Burlington, Canada
  • FEI: 3003516782
Add To Cart